Contract Specifications

Instrument Type Underlying Expiry Date Option Type Strike Price Market Lot

Price Information

Last Price Today's Change Underlying value
 0.00   [0]  0.00
Open  0.00
Prev Close  0.00
Today's Range  0.00 - 0.00
Average Price  0.00
Buy(size)  0.00
Sell(size)  0.00

Turnover Open Interest Information

Volume Turnover Open Interest Change in OI %Change in OI
 0.00  0.00  0.00   [0.00]   [0]
FIIs trend in derivatives
Instruments Buy[Rs.Cr] Sell[Rs.Cr] Net Positions [Rs.Cr] Contracts ['000s] OI Value[Rs.Cr]
Index Futures 1,369.63 2,197.61 [827.98] 258.78 10,518.55
Index Options 10,515.80 9,607.38 908.42 1,493.47 60,433.08
Stock Futures 1,699.20 2,458.38 [759.18] 1,293.08 48,186.30
Stock Options 1,669.68 1,653.66 16.02 60.64 2,238.82

Gold prices near two week low

India Infoline News Service Nov-21-2017

old prices broke the important support level of 29,420 and gave a daily close below it.

Tea stocks jump amid reports of tea price hike

India Infoline News Service Nov-21-2017

cleod russel shot up by over 12%; Jayshree Tea rose over 6%; Williamson Magor zoomed over 9% and Rossell India shot up by 7% in a single trading session.

Dr Reddys rises 5%; USFDA says Duvvada unit status unchanged

India Infoline News Service Nov-21-2017

he company said the FDA inspection has not closed, and the site's status remains unchanged. The company is planning to request a re-inspection in 2018 after further discussion on scheduling with FDA.

Pharma stocks outperform, Nifty ends the session marginally higher

India Infoline News Service Nov-21-2017

harma stocks outperformed during the day with Dr. Reddy's and Sun Pharma gaining 5% and 4% respectively.

Asian Indices end higher as investors eye global growth

India Infoline News Service Nov-21-2017

enchmark Asian Indices end on a positive note on the back of strong economic data in Germany and USA.

Sensex ends higher, gains over 100 points on back of Pharma stocks

India Infoline News Service Nov-21-2017

ensex and Nifty ended trade on a positive note for the second session this week, after Pharma stocks bloomed.